Laboratory of Neurodegenerative Disorders, Department of Neurology, National Clinical Research Center for Geriatrics, West China Hospital, Sichuan University, Chengdu, China.
J Eur Acad Dermatol Venereol. 2022 Jul;36(7):1104-1112. doi: 10.1111/jdv.18072. Epub 2022 Mar 23.
Although hyperhidrosis is a common symptom in patients with Parkinson's disease (PD), no study has yet examined it longitudinally.
We conducted a 3-year prospective cohort study to investigate the development, evolution and correlates of hyperhidrosis in patients with PD.
A total of 224 patients with early-stage PD were enrolled at baseline and followed up annually for three consecutive years. Hyperhidrosis was assessed using hyperhidrosis question (item 30) of the Non-Motor Symptoms Scale (NMSS). The generalized estimating equations model was applied to investigate the correlates of both presence and severity of hyperhidrosis.
The frequency of hyperhidrosis in PD had an overall increasing tendency from 24.1% at baseline to 34.4% after 3 years, although hyperhidrosis was not always persistent in all patients over the 3-year study period. The presence of hyperhidrosis was found to be associated with dyskinesia (OR 2.27 [1.02-5.04], P = 0.045), the sexual function domain subscore of the NMSS (OR 1.04 [1.01-1.07], P = 0.016), the Hamilton Anxiety Rating Scale (HARS) score (OR 1.08 [1.03-1.13], P = 0.001) and the Unified Parkinson's Disease Rating Scale part III score (OR 1.02 [1.00-1.04], P = 0.036). Only the HARS score was associated with the severity of hyperhidrosis (B 0.08 [0.03-0.12], P = 0.001).
Hyperhidrosis is common in PD, and its frequency increases along with disease duration. Hyperhidrosis in PD is associated not only with motor severity and motor complication such as dyskinesia, but also with non-motor symptoms such as sexual dysfunction and anxiety.
尽管多汗症是帕金森病(PD)患者的常见症状,但尚无研究对其进行纵向研究。
我们进行了一项为期 3 年的前瞻性队列研究,以调查 PD 患者多汗症的发展、演变及其相关因素。
共纳入 224 例早期 PD 患者,在基线时进行评估,并在接下来的 3 年内每年进行一次随访。使用非运动症状量表(NMSS)的多汗症问卷(项目 30)评估多汗症。应用广义估计方程模型来研究多汗症存在和严重程度的相关因素。
PD 患者的多汗症频率总体呈上升趋势,从基线时的 24.1%增加到 3 年后的 34.4%,尽管在 3 年的研究期间,并非所有患者的多汗症都一直持续存在。存在多汗症与异动症(OR 2.27[1.02-5.04],P=0.045)、NMSS 的性功能域子评分(OR 1.04[1.01-1.07],P=0.016)、汉密尔顿焦虑量表(HARS)评分(OR 1.08[1.03-1.13],P=0.001)和帕金森病评定量表(UPDRS)第三部分评分(OR 1.02[1.00-1.04],P=0.036)相关。只有 HARS 评分与多汗症的严重程度相关(B 0.08[0.03-0.12],P=0.001)。
PD 患者中多汗症很常见,其频率随着疾病持续时间的增加而增加。PD 患者的多汗症不仅与运动严重程度和运动并发症(如异动症)有关,还与非运动症状(如性功能障碍和焦虑)有关。